QA: Nascent Biotech Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001622057_2022_Nascent_Biotech_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001622057, Nascent Biotech Inc

  xvar xval
0 AssetsCurrent 751,435
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 1,223,940
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 2,150,368
11 remainder_Revenues 750,000
12 remainder_NetIncome 441,601
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 751,435
1 Liabilities 1,223,940
2 Expenses 2,150,368
3 Revenues 750,000
4 StockholdersEquity -472,505
5 NetIncome -958,767
6 ComprehensiveNetIncome -958,767
7 BaseVar 2,658,672
8 EconomicCapitalRatiobeforeLimitedLiability -2.01
9 EconomicCapitalRatio 1.02

Edgar->Model Mapping

Feature Distribution

Change over Time